clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT03950609 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | United States of America | Q30 |
P582 | end time | 2021-05-07 | |
P1050 | medical condition | multiple endocrine neoplasia | Q1553018 |
multiple endocrine neoplasia type 1 | Q3347154 | ||
P2899 | minimum age | 18 | |
P1132 | number of participants | 32 | |
P4844 | research intervention | sirolimus | Q32089 |
P580 | start time | 2019-06-30 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | A Phase II Study of Lenvatinib in Combination With Everolimus in Patients With Advanced Carcinoid Tumors |
Search more.